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Despite public health and veterinary public health improvements within 
the past century, human and animal populations remain vulnerable to health 
threats caused by infectious diseases. Noticeably, the rate of emerging infec-
tious diseases is increasing (one new emerging or re-emerging disease every 
eight months). Meanwhile, many endemic diseases have increased in inci-
dence. Out of 1,400 microbes that could cause human infections, more than 
60% are also pathogenic for wild or domestic animals (OIE, 2012). These 
zoonotic agents cause 75% of human emerging infections (OIE, 2012). 
Since they can be contagious to humans or compromise the food safe-
ty, the infectious diseases of animals represent a direct public health issue 
(OIE, 2012). They also carry an indirect threat since they account for the 
majority of the 20% losses that affect the livestock sector at the production 
level and since they could severely hamper the animal traction resources 
that are needed to produce or transport goods. These losses raise an issue of 
food security to sustain an increasing demand for proteins of animal origin. 
By 2020, the livestock sector is expected to represent 50% of the agriculture 
outputs in value. In developing countries, uncontrolled re-emergence of in-
fectious diseases threatens the main asset of families, thus preventing them 
to escape from poverty. Additionally, the animal morbidity and mortality 
generated by infections represent an unjustified emission of greenhouse 
gases, thus raising an environmental issue. In a growing number of coun-
tries, infections are also perceived as a primary concern for animal welfare.
The rapid pace of infection emergence is not only connected to more 
suitable conditions for pathogen appearance and spreading, it is also linked 
to improved methods and technologies for surveillance, pathogen detection, 
and identification. There are all kinds of pathogen agents of concern: prion, 
viruses, bacteria, and mono-cellular and pluri-cellular parasites. Several 
drivers of infectious diseases have been identified, many of which are of 
anthropogenic origin:
i) Indeed, the role of the expansion and intensification of animal agri-
culture has been pointed out. Changes in nutritional and agricultural 
practices, associated to the second livestock revolution (1980s through 
1990s), have led to intensive production systems, the frequent use of an-
timicrobial agents, high densities of animals with suboptimal husbandry 
conditions, and a decline in genetic diversity.
ii) The ongoing global change and the resulting climate-driven environ-
mental change, as well as natural disasters, have introduced ecological 
perturbations and flux shifts into finely tuned ecosystems consisting, for 
example, in modified interactions between pathogen vectors and hosts.
iii) The population growth, associated with a facilitated access to travel 
means, has a strong impact. Socio-economical determinants such as po-
litical instability and the resulting migrations should be emphasized.
iv) Fast and large-range trade of animal and food products have a major 
influence. Various kinds of changes in food-processing practices were 
also strongly influential. 
v) Several shifts in land use should be mentioned such as: accelerated 
urbanization, deforestation, and the encroachment on wildlife with exten-
sive and closer contacts among humans, livestock animals, and wildlife. 
Species barriers crossing often occur at ecological interfaces. 
vi) Finally, it should be stressed that countries where a capacity break-
down occurs in the domains of public health and animal health manage-
ment, become a weak link in the global effort to prevent, detect, and re-
spond to disease outbreaks. Moreover, poor socio-economic conditions 
are generally associated with closer contacts between humans and ani-
mals, as well as greater exposure to vectors, thus increasing the risk of 
disease emergence in these countries.
In view of these main drivers, which create interconnected risks, what 
strategy would be appropriate to tackle the diversity of research needs and 
challenges? Obviously, an effective approach to emerging diseases that un-
derstands prevention and control will require a broad view of medicine. 
It should encompass biological, ecological, evolutionary, epidemiological, 
and socio-economic determinants of the microbial, animal, human, and 
environmental interacting compartments. Such a broad perspective is fully 
consistent with the “One Health” concept. Within this strategic framework, 
the challenges of emerging infectious diseases will be addressed at the ani-
mal–human–ecosystem interfaces. In their 2010 tripartite concept note, the 
three agencies, FAO, OIE, and WHO, reached a clear strategic alignment 
and delivered an accurate vision statement seeking “a world capable of 
preventing, detecting, containing, eliminating, and responding to animal 
and public health risks attributable to zoonoses and animal diseases with 
an impact on food security through multi-sectorial cooperation and strong 
partnership” (FAO, OIE, and WHO, 2010.). Many research institutions 
have already endorsed this vision, which provides an appropriate frame-
work to foster all of the research needs for the future. It remains a matter 
of debate whether the capacities in public health management and animal 
health management fulfill all criteria of a global public good (non-rivalrous, 
non-excludable, and available worldwide). 
Nonetheless, the goal to improve the capacities in veterinary public 
health management is consistent with the perspective to provide such a © Lefrançois and Pineau
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public good provided that it is considered a worldwide issue to be treated 
through international cooperation. It remains crucial to tackle production 
diseases as well as epidemic emerging diseases. Thus, veterinary medicine 
services should be maintained and developed at a global scale. Such a goal 
is fully consistent with the One Health strategy, but it would not be prop-
erly achieved through the simplistic management hypothesis of merging 
veterinary services with their human health counterparts. Ideally, upstream 
research and field data should provide all necessary substrates for a reliable 
risk assessment. This, in turn, is expected to promote evidence-based deci-
sion making for efficient risk management. In order to prevent, detect, and 
respond to disease outbreaks, such a broad view is essential for policy mak-
ing, surveillance prioritization, validation/dissemination of practices, and 
strategic anticipation. 
A key link in the chain of knowledge is surveillance. To address sani-
tary issues and to strengthen veterinary public health, reliable surveillance 
structures are crucial to provide trustable early warnings. But surveillance 
implementation remains uneven at a global scale. A paradigm shift may oc-
cur in this domain if the access to high-throughput sequencing technologies 
would become more affordable while addressing the subsequent bottleneck 
represented by the data collection, processing, and mining steps. These con-
ceptual and technological improvements may soon place the goal of global 
and reliable pathogen surveillance within reach. Addressing the issue of 
poor reporting should improve the reliability of surveillance if surveillance 
management is improved in parallel. Developed countries could expect 
valuable outcomes and returns on investments from sustaining research and 
capacity building in developing countries of the inter-tropical areas. Ad-
dressing, through cooperation, the infrastructure weaknesses responsible for 
infection emergence is a wise and beneficial strategy for countries that can 
afford it. International cooperation will enable use of all competencies and 
capacities from northern and southern countries and laboratories in tight 
cooperation with international organizations to maintain the objective of 
global public good. This will also enable research-driven developement in 
emerging countries. 
Enablers such as genomics and bioinformatics could help close current 
research gaps. Thus, they strongly influence the definition of research pri-
orities. We believe that several key features will markedly impact the future 
trends in emerging diseases research:
i) The challenges to address, such as the ecological interfaces between 
species, are increasingly complex. They will require inter- or trans-disci-
plinary and collaborative researches.
ii) In this respect, human sciences have to be associated with emerging 
diseases research. For example, in a vaccination control strategy for a giv-
en pathogen, sociologists could help to better understand the perception 
of risks by farmers and stakeholders, and economists would anticipate the 
willingness to pay for prevention measures according to how the threat 
intensity is perceived. In the context of climate-driven ecological change, 
one might expect a renewal of entomology to better address, with other 
disciplines, the challenges of vector-borne diseases. 
iii) With high-throughput strategies, a decline in hypothesis-driven inves-
tigations would be observed whereas data-driven research would likely 
be promoted. These large-scale strategies, when applied to emerging dis-
eases, should provide original causative hypotheses of disease transmis-
sion, which should be tested within a statistical framework.
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iv) Researchers will be strongly encouraged to add a modeling dimen-
sion to their observational research. Then, the ultimate step would be to 
produce predictive outputs from their modeling efforts.
v) Although cell culture models are becoming very popular, widely used, 
and extremely useful, limited and controlled experimental infections on 
live animals will remain an invaluable source of knowledge. Investi-
gating the complexity of animal–pathogen dialog in various organs or 
studying natural infections through insect or acarian vectors is only con-
ceivable in whole organisms. Studies on vector competence or pathogen 
transmissions will be more frequently required while high-throughput 
methods will likely reveal many, yet unknown, pathogens. Therefore, 
high-containment animal facilities represent highly strategic assets when 
quick responses to pathogen outbreaks are expected. Both model spe-
cies and target species remain fully necessary for several crucial steps 
of assessing the determinants of pathogenicity and the host specificity of 
emerging pathogens to produce the first sera for diagnosis tests; assess the 
impact on gonads, gametes, and embryos; and test vaccine efficacy and 
innocuity. Additionally, better than rodents, several livestock species have 
proven to be reliable models to study and respond to human diseases. 
Addressing the threat of an emerging disease (zoonotic or enzootic) does 
not often represent a primary concern on the political agenda. Despite fre-
quent misguiding media treatment and many non-rigorous criticisms made 
before a thorough assessment of impacts, the H1N1 pandemic of 2009–
2010 represents the first global and full-range (from monitoring to vacci-
nation) response to a pathogen emergence. The way all stakeholders have 
contributed to a collaborative process of that size represents a unique and 
enriching experience that should be remembered for its positive outcomes. 
This emphasizes how important it is that policy makers, international agen-
cies, governments, academic researchers, surveillance specialists, diagnosis 
and vaccine providers, and all relevant stakeholders contribute to raise the 
overall level of preparedness to appropriately respond to infectious emerg-
ing diseases. In that respect, considering that resources are scarce, research-
ers are facing the responsibility to address the crucial question of topic pri-
oritization. This is a mandatory step for improved coordination in research 
at a global scale. The priority settings for the strategic plans of influential 
agencies or institutions and some EU-funded projects have already contrib-
uted to research prioritization and coordination that deserves to be further 
pursued. Thorough foresight studies, providing various scenarios for the 
future of livestock production and their consequences in terms of animal 
health and managing emerging infections would be extremely helpful. 
According to foreseen drivers and the ongoing climate-driven ecological 
change, numerous interferences ultimately disturb the vulnerable ecosys-
tem equilibrium among the pathogens, hosts, and vectors. Thus, pathogens 
gain access to new ecological niches, territories, and hosts. Confronted to 
dynamic instabilities, the pathogens respond to uncertainty or threats by 
mobilizing their ancestral and best weaponry system: their unmatched ge-
nome plasticity and fast adaptation to changing environments. In an effort to 
preserve or restore the equilibrium, humans respond with improved surveil-
lance, technological, and medical innovation for drug and vaccine research. 
Between pathogens and hosts, the race is still on to quickly counteract the 
efforts of the other party to tip the balance on its favor. Humans are racing 
for two objectives: securing their own health and their livestock supplies. 
Lederberg (2000) writes, “The future of humanity and microbes will un-
fold as episodes of a suspense thriller that could be titled Our Wits Versus 
Their Genes.” Let’s call for global “Human Intelligence” using international 
cooperation, disciplinary integration, and generosity to tackle the complex 
issue of pathogen emergence.
This issue of Animal Frontiers focuses on four different emerging dis-
eases across the globe, including peste des petis ruminants virus (Libeau 
et al., 2014), Leopeopheirus salmonis (Igboeli et al., 2014), transmissible 
spongiform encephalopathy (Beringue and Andreoletti, 2014),  and porcine 
epidemic diarrhea virus (Kehrli et al., 2014). In addition, Frederick Lantier 
(2014) underscores the necessity and the requirements for the development 
of appropriate animal models to empirically investigate emerging diseases 
in food animals.
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